A Single Dose of Pembrolizumab in HIV-Infected People
Clinical trial NCT03367754 · TERMINATED
Trial details
- NCT number
- NCT03367754
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2021-12-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.